Pharmaceutical Technology

NOVEMBER 17, 2022

This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike. This delay in diagnosis ultimately leads to disease progression and associated complications, such as chronic pelvic pain and infertility, which greatly affects the patients’ quality of life.

Management 102

Management Pharmacology Side effects Patients 102

Clarivate

SEPTEMBER 11, 2024

Timely and accurate diagnosis is critical to maximize the efficacy of available interventions – but for most individuals, the diagnostic journey remains long, complex and costly (Alzheimer’s Disease International, 2021; Chiari, 2022; Juganavar, 2023). In 2022, the U.S. 2024; Quanterix, 2024). Food and Drug Administration, n.d.),

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

MedCity News

JUNE 16, 2023

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 110

Pharma Food and Drug Administration Recruitment Patients 110

Map My Customers

MARCH 31, 2022

As a pharmaceutical sales rep, there are appointments and meetings with doctors and professionals that need to stay up to date with the latest pharmacology treatment options for their patients. Pharmaceutical sales representatives will be the face of the company for drug and treatment manufacturers.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

European Pharmaceutical Review

OCTOBER 19, 2022

10 There is a fear that such practices discourage innovative approaches, impacting on patient welfare. Cited 25 September 2022]. Cited 25 September 2022]. Letter to FDA, 06 July 2022. Cited 25 September 2022]. Cited 25 September 2022]. link] [Cited 25 September 2022]. Cited 25 September 2022].

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

Pharmaceutical Technology

MARCH 17, 2023

As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and on the market. Companies are testing the use of digital platforms along with pharmacological treatments. The potential cost of these approaches is also an obstacle.

Prescription 111

Prescription Pharmacology Pharma Medical 111

European Pharmaceutical Review

JANUARY 18, 2024

billion in 2022 to $4.1 The company predicted this will be “driven by an increase in the patient share of dual orexin receptor antagonists (DORAs)”. percent between 2022 and 2032. percent between 2022 and 2032. percent from $3.2 billion in 2032. million in sales by 2032.

Marketing 98

Marketing Sales Pharmacology Pharma 98

Impetus Digital

AUGUST 2, 2024

From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%. The pharmaceutical industry has numerous use cases for AI.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

pharmaphorum

JANUARY 17, 2023

Angion Biomedica ended 2022 in the midst of a strategic review after its lead drug for kidney diseases flamed out, and it has now charted a path forward – a reverse merger with clinical-stage biotech Elicio Therapeutics.

Pharmacology 69

Pharmacology Engineering Consulting Leads 69

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US. The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

pharmaphorum

DECEMBER 22, 2022

Also tipped as a blockbuster, Zeposia has been gathering momentum with sales doubling to $171 million in the first nine months of 2022. Pfizer reckons the pharmacology of etrasimod – including its engagement with S1P 1, 4 and 5 receptor subtypes – differentiates the drug from its rival, which binds mainly to subtypes 1 and 5.

Pharmacology 52

Pharmacology Safety Patients Marketing 52

European Pharmaceutical Review

JULY 18, 2024

1 As they can be highly targeted in their action, they could become the treatment of choice for clinicians and patients due to the reduced risk of side effects. This class also seem to be better tolerated across patients. Ultimately, this means that we do not yet know how to translate the potential of an ADC into a real patient impact.

Food and Drug Administration 59

Food and Drug Administration Engineering Pharmacology Side effects 59

pharmaphorum

JANUARY 16, 2023

Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà vu that the exact same prediction is contemplated for 2023. The European Medicine Agency-approved Biomarin’s Haemophilia A gene therapeutic, Roctavian, in 2022, and it is expected to be approved by the FDA in 2023.

FDA 85

FDA Healthcare Healthcare Medicine 85

Pharmaceutical Technology

FEBRUARY 8, 2023

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

pharmaphorum

SEPTEMBER 26, 2022

Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks.

Pharmacology 52

Pharmacology FDA Marketing Pharma 52

European Pharmaceutical Review

DECEMBER 11, 2023

The first approved ASO was designed for injection directly into the eye for the local treatment of cytomegalovirus (CMV) retinitis in immunocompromised AIDS patients. Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities.

Safety 98

Safety Pharmacology Engineering Medical 98

Pharmaceutical Technology

NOVEMBER 3, 2022

There, Boehringer had earlier warned of the impending alteplase shortage in April 2022. And patients can die when we do not have these readily available,” he says. Those acute cases of shortage need clinical responses like conservation methods to prioritise patients who need the treatment the most, explains Beavers.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111

Legacy MEDSearch

AUGUST 25, 2022

The PiCSO-AMI-II multicenter, randomized trial will enroll 300 patients with anterior ST-segment Elevation Myocardial Infarction (STEMI) presenting with TIMI flow 0, 1, and 2 within 12 hours of symptom onset. PiCSO therapy is a promising new therapy to reduce infarct size and improve outcomes in anterior STEMI patients. said Prof. “In

Medical 52

Medical FDA Recruitment Pharmacology 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

pharmaphorum

JANUARY 23, 2023

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022. It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes.

Pharma 82

Pharma Food Pharmacology Patients 82

Pharmaceutical Technology

AUGUST 8, 2022

Proteus Health’s Abilify MyCite had an ingestible sensor that could track if a patient consumed the drug. You don’t want to use this to stigmatize patients or to ‘catch them lying.’ The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122